| Literature DB >> 28862674 |
Hui-Na Lin1,2, Kai-Ling Wang3,4, Ze-Hong Wu5,6, Ren-Mao Tian7, Guo-Zhu Liu8, Ying Xu9.
Abstract
The aim of this research is to explore the biological and chemical diversity of bacteria associated with a marine flatworm Paraplanocera sp., and to discover the bioactive metabolites from culturable strains. A total of 141 strains of bacteria including 45 strains of actinomycetes and 96 strains of other bacteria were isolated, identified and fermented on a small scale. Bioactive screening (antibacterial and cytotoxic activities) and chemical screening (ultra-performance liquid chromatography-mass spectrometry (UPLC-MS)) yielded several target bacterial strains. Among these strains, the ethyl acetate (EA) crude extract of Streptomyces sp. XY-FW47 fermentation broth showed strong antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC43300 (MRSA ATCC43300) and potent cytotoxic effects on HeLa cells. The UPLC-MS spectral analysis of the crude extract indicated that the strain XY-FW47 could produce a series of geldanamycins (GMs). One new geldanamycin (GM) analog, 4,5-dihydro-17-O-demethylgeldanamycin (1), and three known GMs (2-4) were obtained. All of these compounds were tested for antibacterial, cytotoxic, and antifungal activities, yet only GM (3) showed potent cytotoxic (HeLa cells, EC50 = 1.12 μg/mL) and antifungal (Setosphaeria turcica MIC = 2.40 μg/mL) activities. Their structure-activity relationship (SAR) was also preliminarily discussed in this study.Entities:
Keywords: Paraplanocera sp.; Streptomyces sp.; bacteria; geldanamycin; marine flatworm; natural products
Mesh:
Substances:
Year: 2017 PMID: 28862674 PMCID: PMC5618420 DOI: 10.3390/md15090281
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of geldanamycin and its analogs.
Figure 2Photo of the Paraplanocera sp. used in this study.
Figure 3Maximum likelihood tree showing the phylogenetic position of the Paraplanocera sp. based on the 18S rRNA gene (1260 bp).
The diversity of the culturable bacteria derived from the marine flatworm Paraplanocera sp. A total of 141 strains of bacteria, including 37 species of actinobacteria and 64 species of non-actinobacteria, were identified by comparison 16S rDNA sequences of the isolates with their reference strains in the GeneBank of NCBI. All the known isolates have high identity percentage values with 98.5–100% except the three new species (Pseudovibrio hongkongenesis UST20140214-015B [15], Pseudovibrio stylochi UST20140214-052 [16], and Deinococcus planocerae XY-FW106 [17]).
| Species | Isolate ID | Accession Number of the Most Similar Strain | Species | Isolate ID | Accession Number of the Most Similar Strain | |
|---|---|---|---|---|---|---|
| Actinobacteria | XY-FW38 | JN180219 | XY-FW60 | KF378757 | ||
| XY-FW46 | FJ99174 | XY-FW63 | NZ_MVID01000062 | |||
| XY-FW47 | MF664376 | XY-FW64 | AF537362 | |||
| XY-FW121 | EF515876 | XY-FW71 | AB239925 | |||
| XY-FW57W | D63873 | XY-FW80 | JN627174 | |||
| XY-FW100W | AB184150 | XY-FW83 | JYNX01000034 | |||
| XY-FW107 | JNXT01000131 | XY-FW90 | FJ172308 | |||
| XY-FW109 | AY999794 | XY-FW62 | HQ009482 | |||
| XY-FW120 | AB184326 | XY-FW77 | HQ009482 | |||
| XY-FW137 | AB184439 | XY-FW102 | AB004719 | |||
| XY-FW153 | AB184264 | |||||
| XY-FW154 | AY785161 | XY-FW145 | BCRA01000173 | |||
| XY-FW134 | JQ345722 | XY-FW86 | FJ643549 | |||
| XY-FW142 | JQ345722 | |||||
| XY-FW94 | AB107231 | XY-FW101 | AF283283 | |||
| XY-FW95 | KC517406 | XY-FW82 | X76567 | |||
| XY-FW99 | KM370042 | XY-FW48A | FJ214355 | |||
| XY-FW123 | EU196562 | XY-FW75 | FJ214355 | |||
| XY-FW130 | KY818670 | XY-FW120A | EF660748 | |||
| XY-FW132 | KM370074 | XY-FW148 | EF114314 | |||
| XY-FW65 | JQ768361 | |||||
| XY-FW69 | CP002162 | XY-FW149 | EF114314 | |||
| XY-FW97 | CP002162 | |||||
| XY-FW122 | CP002162 | |||||
| Non-actinobacteria | XY-FW24 | KX082867 | XY-FW48B | KP640585 | ||
| XY-FW37 | AF492815 | XY-FW54 | KP640585 | |||
| XY-FW43 | KM036072 | XY-FW31 | JQ807219 | |||
| XY-FW50 | KY243945 | XY-FW32 | JQ807219 | |||
| XY-FW53 | KR476448 | XY-FW40 | JQ807219 | |||
| XY-FW55 | KY580789 | XY-FW45 | JQ807219 | |||
| XY-FW66 | ASJC01000029 | XY-FW58 | JQ807219 | |||
| XY-FW105 | FN597644 | XY-FW72 | JQ807219 | |||
| XY-FW96 | JQ807219 | |||||
| XY-FW112 | KX951942 | XY-FW138 | JQ807219 | |||
| XY-FW125 | NZ_JANV01000041 | UST20140214-015B | KP207599 | |||
| XY-FW131 | KF060662 | [ | ||||
| XY-FW1A | MF597792 | UST20140214-052 | KP207600 | |||
| XY-FW5 | MF429570 | XY-FW21B | LN812993 | |||
| XY-FW23 | KY777466 | XY-FW51 | LN812993 | |||
| XY-FW49 | KY753251 | XY-FW57 | LN812993 | |||
| XY-FW30 | MF062965 | XY-FW78 | KY436215 | |||
| XY-F W59 | MF062965 | XY-FW42 | KY471632 | |||
| XY-FW110 | EF114313 | XY-FW3 | KY229808 | |||
| XY-FW117 | EF114313 | XY-FW17 | EU106662 | |||
| XY-FW116 | EU656111 | XY-FW21A | MF429388 | |||
| XY-FW126 | EU656111 | XY-FW21C | AY608408 | |||
| XY-FW133 | EU656111 | XY-FW28 | KC178948 | |||
| XY-FW139 | EU656111 | XY-FW56 | EU156066 | |||
| XY-FW113 | AY904033 | XY-FW67 | KY010351 | |||
| XY-FW115 | AY904033 | XY-FW73 | KX068643 | |||
| XY-FW118 | AY904033 | XY-FW106 | KT886059 | |||
| XY-FW129 | AY904033 | XY-FW111 | KY933473 | |||
| XY-FW136 | AY904033 | XY-FW114 | AJ575658 | |||
| XY-FW7B | KY382786 | XY-FW119 | CP007597 | |||
| XY-FW19 | LN832958 | XY-FW124 | DQ342239 | |||
| XY-FW34A | JQ799098 | XY-FW141 | JX986974 | |||
| XY-FW34B | KX507262 | XY-FW146 | AUBT01000026 | |||
| XY-FW68 | LT635432 | |||||
| XY-FW10 | NZ_FOOG01000089 | |||||
| XY-FW16 | NZ_FOOG01000089 | |||||
| XY-FW27 | KY176867 | |||||
| XY-FW39 | KT758460 |
The antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC43300 (MRSA ATCC43300) of the bacteria associated with Paraplanocera sp.
| Bacteria Associated with | Tested Pathogen | |
|---|---|---|
| Isolate ID | Closest Described Species | MRSA ATCC43300 |
| XY-FW47 | +++ | |
| XY-FW142 | +++ | |
| XY-FW153 | +++ | |
| XY-FW120 | +++ | |
| XY-FW120A | ++ | |
| XY-FW105 | ++ | |
| XY-FW56 | + | |
| XY-FW48A | + | |
Final sample concentration: 100 μg/mL; + represents weak activity (0.2 < OD ≤ 0.4); ++ represents moderate activity (0.1 < OD ≤ 0.2); +++ represents high activity (0.05 < OD ≤ 0.1); Negative control with DMSO (OD ≈ 0.8); Positive control with vancomycin (OD ≈ 0.05).
The cytotoxic activity of the bacteria associated with Paraplanocera sp.
| Bacteria Associated with | Cell Line | |
|---|---|---|
| Isolate ID | Closest Described Species | HeLa Cell |
| XY-FW47 | +++ | |
| XY-FW120 | +++ | |
| XY-FW142 | ++ | |
| XY-FW153 | ++ | |
| XY-FW124 | ++ | |
| XY-FW105 | + | |
| XY-FW100W | + | |
Final sample concentration: 100 μg/mL; + represents weak activity (0.2 < OD ≤ 0.4); ++ represents moderate activity (0.1 < OD ≤ 0.2); +++ represents high activity (0.05 < OD ≤ 0.1); Negative control with DMSO (OD ≈ 0.8).
Figure 4Ultra-performance liquid chromatography–mass spectrometry (UPLC-MS) analysis and ultraviolet (UV) spectra of the crude extract of XY-FW120. The main metabolite produced by XY-FW120 is actinomycin D.
Figure 5UPLC-MS analysis and UV spectra of the crude extract of XY-FW47: (1) compounds with HR-ESI-MS [M − H]− 547.2805, 533.2992 and 547.2636 in red are very likely novel GMs (highlighted by red color); and (2) compounds with HR-ESI-MS [M − H]− 545.2548, 559.2783 and 561.2936 in black show to be known 17-O-demethylgeldanamycin, GM and 4,5-dihydrogeldanamycin (highlighted by black color).
1H and 13C NMR data for Compound 1 in CDCl3.
| Position | Position | ||||
|---|---|---|---|---|---|
| 1 | 168.3, C | 16 | 117.2, C | ||
| 2 | 133.1, C | 17 | 152.8, C | ||
| 3 | 138.4, CH | 6.25, t (6.7) | 18 | 183.0, C | |
| 4 | 24.4, CH2 | 2.42, m | 19 | 107.4, CH | 7.28, s |
| 5 | 29.6, CH2 | 1.77, m | 20 | 140.8, C | |
| 6 | 80.9, CH | 3.37, m | 21 | 184.3, C | |
| 7 | 80.3, CH | 5.18, d (4.2) | NH | 8.99, s | |
| 8 | 131.0, C | 22-CH3 | 12.3, CH3 | 1.91, s | |
| 9 | 133.8, CH | 5.68, d (9.6) | 23-OCH3 | 59.0, CH3 | 3.41, s |
| 10 | 32.5, C | 2.77, m | 24-OCONH2 | 156.1, C | |
| 11 | 73.3, CH | 3.58, d (7.8) | 25-CH3 | 12.5, CH3 | 1.68, s |
| 12 | 82.5, CH | 3.38, m | 26-CH3 | 12.7, CH3 | 0.96, d (7.5) |
| 13 | 34.9, CH2 | 1.73, m | 27-OCH3 | 57, CH3 | 3.35, s |
| 14 | 28.3, CH | 1.75, m | 28-CH3 | 22.6, CH3 | 0.98, d (7.5) |
| 15 | 32.0, CH2 | 2.40, m 2.48, dd (13.2, 3.2) |
Figure 6Key COSY and HMBC correlations of Compound 1.